https://scholars.lib.ntu.edu.tw/handle/123456789/434924
標題: | Consensus guidelines for the management of atopic dermatitis: An Asia-Pacific perspective | 作者: | Rubel D. Thirumoorthy T. Soebaryo R.W. Weng S.C.K. Gabriel T.M. Villafuerte L.L. CHIA-YU CHU Dhar S. Parikh D. Wong L.-C. Lo K.-K. |
公開日期: | 2013 | 卷: | 40 | 期: | 3 | 起(迄)頁: | 160-171 | 來源出版物: | Journal of Dermatology | 摘要: | Atopic dermatitis (AD) is a relatively common disease in patients in the Asia-Pacific region. It presents a particular clinical challenge and requires careful clinical management. The chronic nature of AD characterized by flares, exacerbations and periods of quiescence requires a multipronged approach aimed at reducing itch, inflammation and the appearance of secondary lesions. In addition, varying levels of maintenance therapy may be required to avoid exacerbations. Survey data from the region indicate that there is significant variation across the Asia-Pacific with regard to current treatment practices. The management of AD may also be influenced by differing health-care systems, variable climate, access to medical care and cultural diversity. The current consensus guidelines have been developed to provide up-to-date and concise evidence- and experience-based recommendations directed towards general practitioners and general dermatologists in the Asia-Pacific region on the management of pediatric and adult AD. ? 2013 Japanese Dermatological Association. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874473867&doi=10.1111%2f1346-8138.12065&partnerID=40&md5=85a8e69eb58a89946b427b100d8fffc4 https://scholars.lib.ntu.edu.tw/handle/123456789/434924 |
ISSN: | 0385-2407 | DOI: | 10.1111/1346-8138.12065 | SDG/關鍵字: | azathioprine; beclometasone dipropionate; betamethasone valerate; chlorpheniramine; clobetasol propionate; clobetasone butyrate; cloxacillin; corticosteroid; cyclosporin; desonide; diflucortolone valerate; emollient agent; erythromycin; fluticasone propionate; halcinonide; herbaceous agent; hydrocortisone; hydrocortisone butyrate; hydrocortisone valerate; loratadine; methotrexate; methylprednisolone aceponate; mometasone furoate; mycophenolic acid 2 morpholinoethyl ester; pimecrolimus; probiotic agent; psoralen; tacrolimus; triamcinolone acetonide; unindexed drug; acne; adrenal suppression; antibiotic therapy; article; atopic dermatitis; bandage; Chinese herb; consensus; corticosteroid therapy; cultural anthropology; disease severity; drug efficacy; gene mutation; health care access; health care system; human; hypertension; kidney dysfunction; Lactobacillus fermentum; Lactobacillus rhamnosus; moisture; nausea; paresthesia; patient education; photochemotherapy; phototherapy; practice guideline; PUVA; rosacea; side effect; skin atrophy; skin manifestation; stria; telangiectasia; unspecified side effect; Administration, Topical; Adrenal Cortex Hormones; Anti-Infective Agents; Bandages; Calcineurin; Complementary Therapies; Dermatitis, Atopic; Emollients; Histamine Antagonists; Humans; Phototherapy |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。